Product Information
AMLODIPINE-VALSARTAN 5-160 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3721 per EA under NDC 00378172193. Its NADAC has been published 583 times since Apr 29, 2015.
Strength
5; 160 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378172193
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA090483On Market Since
3/30/2015
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN 5-160 MG has been published 583 times since Apr 29, 2015, and over the history we have for it it has declined 91.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3721 per EA |
|---|---|
| All-time high | $4.2444 (Jun 10, 2015) |
| All-time low | $0.3449 (Jul 17, 2024) |
| 52-week high | $0.4954 |
| 52-week low | $0.3721 |
| Median price | $0.4641 |
| Average price | $0.5170 |
| Largest weekly change | -66.9% (Jul 22, 2015) |
| Weeks tracked | 583 |
| Tracking since | Apr 29, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the AMLODIPINE AND VALSARTAN market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN 5-160 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-160 MG, manufactured by Mylan Pharmaceuticals Inc., is $0.3721 per EA (NDC 00378172193), effective Jun 24, 2026.
How has the price of AMLODIPINE-VALSARTAN 5-160 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has declined 91.2%. It has been tracked across 583 weekly CMS publications since Apr 29, 2015.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-160 MG?
Since Apr 29, 2015, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has ranged from a low of $0.3449 (Jul 17, 2024) to a high of $4.2444 (Jun 10, 2015), with a median of $0.4641 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-160 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMLODIPINE-VALSARTAN 5-160 MG, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-VALSARTAN 5-160 MG?
AMLODIPINE-VALSARTAN 5-160 MG (NDC 00378172193) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification